239 results
Page 5 of 12
UPLOAD
s92nbpg
9 May 22
Letter from SEC
12:00am
8-K
EX-10.1
j594 6yw6z09tv66ka
26 Apr 22
Departure of Directors or Certain Officers
6:51am
8-K
EX-10.1
x1qs94z3wip
1 Feb 22
Kiora Pharmaceuticals Appoints Erin Parsons to its Board of Directors; Stephen From to Retire from Board
6:45am
8-K
EX-99.1
y9ggse ih
15 Dec 21
Kiora Pharmaceuticals Appoints David Hollander, MD, MBA, to its Board of Directors
7:00am
8-K
EX-10.1
x0fzr7d36uzkm
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
424B5
kbv1qwa
11 Aug 21
Prospectus supplement for primary offering
6:56am
8-K
EX-4.1
fjjtp6hccx74wxjl9x76
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am